Neuromuscular Block, Residual

2

Review clinical trials related to Neuromuscular Block, Residual. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery

The purpose of this study is to assess the effect of quantitative block monitoring versus less expensive qualitative monitoring treatment effects on the lowest SpO2/FiO2 ratio in the PACU. The results will be incorporated into an enhanced recovery pathway for surgical patients.

Participants needed: 1,032
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: The University of Texas Health Science Center, HoustonUpdated: Oct 10, 2025Locations: 1
Eligibility criteria

Patient age ≥ 18 years old; [+2]

Intubation before induction of anesthesia; [+7]

Status: Not yet recruiting

Methylprednisolone vs Dexamethasone: Effects on Sugammadex Reversal, Pain, and Nausea in Adults

This randomized controlled trial aims to compare the effects of intravenous methylprednisolone and dexamethasone on the reversal time of rocuronium by sugammadex in adult patients undergoing elective septoplasty or rhinoplasty. The primary outcome is the time from sugammadex administration to recovery of a train-of-four (TOF) ratio of 0.9. Secondary outcomes include extubation time, postoperative nausea and vomiting (PONV), pain scores, complications in the post-anesthesia care unit (PACU), and intraoperative hemodynamic parameters. The study will provide new evidence on whether perioperative corticosteroid choice modifies the efficacy of sugammadex and influences postoperative recovery.

Participants needed: 130
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Konya City HospitalUpdated: Sep 22, 2025Locations: 1
Eligibility criteria

Adult patients aged 18-65 years [+3]

ASA physical status ≥ III [+9]